Scientists have discovered that two widely available prescription drugs restore partial cellular folding, trafficking, and function to a variety of mutant enzymes responsible for three distinct lysosomal storage diseases, maladies involving multiple organ system failure. This discovery may increase treatment options for inherited metabolic disease patients.



Recent comments
29 weeks 4 days ago